-5%
Paricel is indicated for the management of:
- Active duodenal ulcer and benign gastric ulcer
- Erosive/ulcerative GERD and long-term GERD maintenance
- Symptomatic GERD (moderate to severe)
- Zollinger–Ellison syndrome
- H. pylori eradication in combination therapy for peptic ulcer disease
Paricel contains Rabeprazole, a potent proton pump inhibitor (PPI).
It blocks the H⁺/K⁺-ATPase enzyme in gastric parietal cells, suppressing gastric acid secretion at its final step—delivering long-lasting acid control and ulcer healing.
